The potential causes of myasthenia and fasciculations in severely ill ME/CFS patients: the role of disturbed electrophysiology.
Wirth, Klaus J, Steinacker, Jürgen M · Frontiers in physiology · 2025 · DOI
Quick Summary
This study proposes that muscle weakness, fatigue, and twitching in severely ill ME/CFS patients may result from a problem with a specific pump in muscle cells called the Na+/K+-ATPase. When this pump doesn't work properly, it allows too much sodium and calcium to build up inside muscle cells, damaging the cell's energy-producing structures (mitochondria) and making muscles weaker and more prone to cramping and involuntary twitching. The researchers suggest this single mechanical problem could explain many of the muscle symptoms severely ill ME/CFS patients experience.
Why It Matters
Understanding the biological mechanisms underlying ME/CFS muscle symptoms is critical for developing targeted treatments. If Na+/K+-ATPase dysfunction is indeed central, it could suggest specific therapeutic interventions that might improve muscle strength and reduce fatigue in severely ill patients. This unifying mechanistic model may also help clinicians better understand why standard neurological testing appears normal in ME/CFS patients despite significant muscle symptoms.
• Standard neurological investigations exclude primary neuronal pathology in these patients
• Previous research has identified mitochondrial dysfunction and intracellular ionic dysregulation in ME/CFS
• Severe orthostatic intolerance and cerebral blood flow reduction are documented features of severe ME/CFS
Inferred Conclusions
• Na+/K+-ATPase pump dysfunction can serve as a unifying mechanism explaining diverse skeletal muscle symptoms in severe ME/CFS
• A self-reinforcing cycle of depolarization and mitochondrial damage perpetuates muscle pathology once initiated
• Sarcolemmal depolarization provides a muscular rather than neuronal explanation for myasthenia and hyperexcitability symptoms
Remaining Questions
• Is Na+/K+-ATPase activity actually reduced in ME/CFS patients, and if so, what causes this reduction?
• What triggers the initial impairment of pump function in ME/CFS?
• Can specific interventions targeting Na+/K+-ATPase function improve muscle symptoms in severely ill patients?
What This Study Does Not Prove
This is a theoretical hypothesis paper without new experimental data demonstrating that Na+/K+-ATPase dysfunction actually occurs in ME/CFS patients or causes their symptoms. The study does not prove causation—it proposes a plausible mechanism based on known physiological principles but does not establish that this is the primary cause rather than a secondary effect. It also does not address why Na+/K+-ATPase function becomes impaired in the first place or provide evidence for the proposed interventions.